Life Sciences Archives - Page 30 of 32

Pan-Mass Challenge Donates Record $78 Million to Dana-Farber Cancer Institute

November 3, 2025

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Expanding Clinical Data Capabilities to Accelerate Drug Development

October 29, 2025

Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

October 27, 2025

THIS WEEK'S STORIES

InterVene Receives FDA Clearance for Recana, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

October 31, 2025

Picard to Showcase Its Total Artificial Heart at the American Heart Association 2025 Annual Meeting

November 3, 2025

Sovato Closes $41 Million Series B to Advance the World’s First Remote Robotic Surgery and Procedure Platform

November 4, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

ASU’s New School of Medicine Receives Preliminary Accreditation, Major Gift, and New Name

Loomis Sayles Partners with ICE Climate to Enhance Global Climate Risk Analysis

Jefferson River Capital Launches Jefferson Life Sciences, a New Early-Stage Investment Firm Focused on Human Health Innovation

Gradiant Expands ForeverGone PFAS Destruction Platform with Breakthrough Cost and Deployment at Munich Airport

Most Read

BrainScope Appoints Matt Adams as Chief Executive Officer to Lead Next Phase of Growth

Colossal Biosciences Acquires Viagen to Strengthen De-extinction and Species Preservation Platform

Tulyp Medical Emerges From Sofinnova’s Medtech Accelerator and Submits FDA Application Following First-in-Human Use

BioIVT Acquires BeCytes to Expand Global Access to Ethically Sourced Human Biospecimens for Research

EDITOR PICKS